XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Disaggregation of Revenues and Concentration Risk
 6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenues and Concentration Risk

7. Disaggregation of Revenues and Concentration Risk

 

The following table presents the percentage of consolidated revenues generated by unaffiliated customers that individually represent greater than ten percent of consolidated revenues:

 

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Pharma services - Company A   68%   -*    27%   -* 
Pharma services - Company B   -*    -*    14%   -* 
Discontinuing operations   -*    89%   38%   82%

 

* Less than 10%

 

The following table presents the percentage of consolidated revenues by products or services classes:

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Pharma Services   94%   11%   62%   18%
DetermaRx™   6%   0%   3%   0%
Discontinuing operations   0%   89%   35%   82%
Total   100%   100%   100%   100%

 

The following table presents the percentage of consolidated revenues attributable to geographical locations:

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
United States – Pharma Services   74%   50%   39%   65%
Outside of the United States – Pharma Services   20%   2%   23%   5%
DetermaRx™   6%   0%   3%   0%
Discontinuing operations – Outside of the United States – Licensing   0%   48%   0%   30%
Discontinuing operations – United States – DetermaRx™   0%   0%   35%   0%
Total   100%   100%   100%   100%